Hyperbaric Chamber Price Index: 26 Verified Listings, Tracked (July 2026)

Hyperbaric chamber price index

Affiliate Disclosure

This article contains affiliate links. If you purchase through these links, we may earn a commission at no additional cost to you. This does not influence our evaluations or rankings.


How we evaluate: Our recommendations are based on published clinical evidence, manufacturer specifications, and real user feedback. We may earn a commission if you purchase through our links, at no extra cost to you. This does not influence our rankings.
Full disclosure.

A soft-shell home hyperbaric chamber has a median listed price of $13,495 across 11 verified July 2026 listings. Personal hard-shell chambers run a median of $41,700, and used clinical monoplace chambers list between $49,500 and $128,625. Every price below was recorded from a live retailer, dealer, or marketplace page on July 23, 2026, with the source linked per row.

Key Takeaways

  • Median listed price for a new soft-shell home chamber is $13,495 (n=11, range $4,495 to $24,372).
  • New personal hard-shell chambers have a median of $41,700 (n=8), with 1.5 to 3.0 ATA ratings.
  • New clinical monoplace chambers are quote-only; the used market lists Perry and Sechrist units at $49,500 to $128,625.
  • Price scales roughly linearly with pressure: both soft 1.3 ATA and hard 2.0 ATA units cost about $4,000 to $4,600 per 0.1 ATA above ambient.
  • All 26 observations were verified on live pages on July 23, 2026 and are linked in the tables below.

Why This Index Exists

Most published chamber prices are either manufacturer marketing, out of date, or estimates with no source. This index only records prices we saw on a live page, with the URL and date attached to each row. We will re-run the sweep periodically so the index tracks how the market moves. If you want the full context on what drives these prices, start with our hyperbaric chamber cost guide and the buying hub.

Soft-Shell Home Chambers (New)

Soft-shell chambers cluster between $4,495 and $24,372, all rated 1.3 to 1.4 ATA. The FDA has cleared these devices for acute mountain sickness only; every other use is off-label. Session pricing is tracked separately in our HBOT session cost by state survey.

Model Manufacturer Max ATA Price (USD) Condition Source
C4-27 (Class 4, 27") Newtowne Hyperbarics 1.3 $4,495 new healingthehyperbaricway.com
Shallow Dive (27") Summit to Sea 1.3 $7,995 new medicalspasupply.com
Dive (33") Summit to Sea 1.3 $9,995 new rehabmart.com
ST901 Soft Lying Macy-Pan 1.3 $10,200 new recovathlete.com
Vitaeris 320 OxyHealth 1.3 $10,500 to $11,000 used incomingclarity.com
40" Portable (Class 4) Newtowne Hyperbarics 1.3 $10,995 new bradshawoxygen.com
Grand Dive Horizontal (40") Summit to Sea 1.3 $13,495 new rehabmart.com
Grand Dive Vertical (54") Summit to Sea 1.3 $16,995 to $17,995 new rehabmart.com
Vitaeris 320 OxyHealth 1.3 $19,900 new airpuria.com
Grand Dive Pro Plus (60") Summit to Sea 1.3 $19,995 new biohackersupply.com
Grand Dive Pro (46") Summit to Sea 1.3 $20,195 new medicalspasupply.com
OxyNova 7 (inflatable) OxyNova 1.4 $21,995 to $26,750 new recoveryforathletes.com

Personal Hard-Shell Chambers (New)

Hard-shell personal units span $27,450 to $136,100. The top of that range is a single dealer listing for the OxyHealth Fortius 420, which diverges sharply from its used-market value near $35,000, so treat it as an outlier rather than the market rate. See our hard-shell vs soft-shell comparison for what the extra pressure actually buys.

Model Manufacturer Max ATA Price (USD) Condition Source
Quest30 Lying Hard OxyRevo 2.0 $24,999 to $29,900 new recovathlete.com
HP1501 Lying Hard Macy-Pan 1.8 $26,500 to $32,500 new recovathlete.com
Fortius 420 OxyHealth 3.0 $35,000 used picclick.com
HP750 Sitting Hard Macy-Pan 2.0 $39,999 new recovathlete.com
HP2202 Lying Hard Macy-Pan 2.0 $40,400 new recovathlete.com
Space60 Sitting Hard OxyRevo 2.0 $42,999 new healthrevival.com
OxyLife I Monoplace OxyHelp 2.0 $46,250 new shop.elevatedlongevity.com
Hyperbaric Oxygen Capsule Hue Light 1.5 $57,995 new huelightusa.com
Fortius 420 OxyHealth 3.0 $136,100 new airpuria.com

Clinical Monoplace Chambers

Sechrist and Perry Baromedical do not publish new-unit pricing; hospitals get quotes. The used market is the only public price signal, and it looks like this:

Model Manufacturer Max ATA Price (USD) Condition Source
Sigma 34 Monoplace (14 dive cycles) Perry Baromedical 3.0 $49,500 used medicalpriceonline.com
Sigma 40 Monoplace Perry Baromedical 3.0 $59,130 used medicalpriceonline.com
3600H Monoplace (2010, low cycles) Sechrist 3.0 $128,625 used medicalpriceonline.com

Multiplace Chambers

Only two multiplace systems had public prices in this sweep, so read these as examples rather than a market median. Installed hospital systems typically run far higher once site work is included; our multiplace chamber guide covers what installation involves.

Model Manufacturer Max ATA Price (USD) Condition Source
HE5000 5-Person Hard Macy-Pan 2.0 $65,100 new recovathlete.com
OxyLife C Multiplace (C2/C3/C4) OxyHelp 2.0 $130,750 new shop.elevatedlongevity.com

Used Market Observations

Model Manufacturer Max ATA Price (USD) Condition Source
Vitaeris 320 OxyHealth 1.3 $10,500 to $11,000 used incomingclarity.com

Used soft and hard chambers listed at roughly 40 to 60 percent of new prices in this sweep, consistent with our used chamber buying guide.

Methodology

We recorded the listed price of every hyperbaric chamber model we could verify on a live US retailer, authorized dealer, manufacturer, or used-equipment marketplace page on July 23, 2026. Quote-only models (Sechrist and Perry new units, AirPod) were excluded rather than estimated. Prices are list prices, not negotiated prices, and exclude delivery, installation, and oxygen equipment unless noted on the source page. Category medians use listing midpoints. Cite as: “BaricBoost Hyperbaric Chamber Price Index, July 2026.”

Medical Disclaimer

The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Seph Fontane Pennock

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website

Why Trust Our Evaluations

Our rankings are based on hands-on testing, published clinical data, and verified manufacturer specifications. We apply the same criteria to every product regardless of affiliate status. Editorial Process · Evaluation Methodology

Previous Article

Oxygen Therapy for COPD: When It Helps, When It Doesn't, and How It Works

Next Article

HBOT Session Cost by State: 27 Published Clinic Prices Compared (July 2026)

One Email a Week.
Better Health Decisions.

Weekly breakdowns of the latest HBOT, ozone therapy, and oxygen therapy research. Clinical insights, treatment protocols, and evidence-based guidance for patients and practitioners.
Trusted by patients, clinicians, and researchers worldwide